Anika Therapeutics, Inc. (ANIK)
14.90
+0.34
(+2.34%)
USD |
NASDAQ |
Mar 26, 13:33
Anika Therapeutics Free Cash Flow : 4.362M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioCryst Pharmaceuticals, Inc. | 327.41M |
| Lantheus Holdings, Inc. | 348.64M |
| TELA Bio, Inc. | -31.50M |
| Plus Therapeutics, Inc. | -20.84M |
| BioStem Technologies, Inc. | 12.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.637M |
| Cash from Investing (Quarterly) | 0.198M |
| Cash from Financing (Quarterly) | -5.279M |
| Free Cash Flow Per Share (Quarterly) | 0.2719 |
| Free Cash Flow to Equity (Quarterly) | 2.248M |
| Free Cash Flow to Firm (Quarterly) | 3.989M |
| Free Cash Flow Yield | 2.03% |